Pursuits
Seven Cancer Drug Billionaires Unmasked as Roche Surges
This article is for subscribers only.
Roche Holding AG, the Basel, Switzerland-based drugmaker that manufactures the world’s best-selling cancer treatment and reached a five-year high this week, has minted at least 12 Swiss and German billionaires. Seven have never appeared individually on an international wealth ranking.
The dozen billionaires, who are drawn from the Engelhorn family of Germany and Switzerland’s Hoffmann-Oeri clan, have a combined fortune valued at more than $35 billion, according to the Bloomberg Billionaires Index.